The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Vaccine Core Enzyme Market Research Report 2025
Synopsis
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The global mRNA Vaccine Core Enzyme market was valued at US$ 2400 million in 2023 and is anticipated to reach US$ 1726 million by 2030, witnessing a CAGR of -2.5% during the forecast period 2024-2030.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine Core Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine Core Enzyme.
The mRNA Vaccine Core Enzyme market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccine Core Enzyme market comprehensively. Regional market sizes, concerning products by Enzyme Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccine Core Enzyme manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Enzyme Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
by Application
Biopharmaceutical Companies
Academic and Research Institutions
Production by Region
North America
Europe
China
Latin America
Middle East & Africa
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Enzyme Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Vaccine Core Enzyme manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Vaccine Core Enzyme in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Enzyme Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The global mRNA Vaccine Core Enzyme market was valued at US$ 2400 million in 2023 and is anticipated to reach US$ 1726 million by 2030, witnessing a CAGR of -2.5% during the forecast period 2024-2030.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine Core Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine Core Enzyme.
The mRNA Vaccine Core Enzyme market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Vaccine Core Enzyme market comprehensively. Regional market sizes, concerning products by Enzyme Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccine Core Enzyme manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Enzyme Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
by Application
Biopharmaceutical Companies
Academic and Research Institutions
Production by Region
North America
Europe
China
Latin America
Middle East & Africa
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Enzyme Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Vaccine Core Enzyme manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Vaccine Core Enzyme in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Enzyme Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 mRNA Vaccine Core Enzyme Market Overview
1.1 Product Definition
1.2 mRNA Vaccine Core Enzyme by Enzyme Type
1.2.1 Global mRNA Vaccine Core Enzyme Market Value Comparison by Enzyme Type (2024-2030)
1.2.2 Capping Enzyme
1.2.3 2'-O-Methyltransferase
1.2.4 Inorganic Pyrophosphatase
1.2.5 Poly (A) Polymerase
1.2.6 Rnase Inhibitor
1.2.7 RNA Polymerase
1.2.8 Restriction Enzyme
1.2.9 Dnase I
1.2.10 Others
1.3 mRNA Vaccine Core Enzyme by Application
1.3.1 Global mRNA Vaccine Core Enzyme Market Value by Application (2024-2030)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutions
1.4 Global mRNA Vaccine Core Enzyme Market Size Estimates and Forecasts
1.4.1 Global mRNA Vaccine Core Enzyme Revenue 2019-2030
1.4.2 Global mRNA Vaccine Core Enzyme Sales 2019-2030
1.4.3 Global mRNA Vaccine Core Enzyme Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 mRNA Vaccine Core Enzyme Market Competition by Manufacturers
2.1 Global mRNA Vaccine Core Enzyme Sales Market Share by Manufacturers (2019-2024)
2.2 Global mRNA Vaccine Core Enzyme Revenue Market Share by Manufacturers (2019-2024)
2.3 Global mRNA Vaccine Core Enzyme Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Type & Application
2.7 Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Enter into This Industry
2.8 Global mRNA Vaccine Core Enzyme Market Competitive Situation and Trends
2.8.1 Global mRNA Vaccine Core Enzyme Market Concentration Rate
2.8.2 The Global 5 and 10 Largest mRNA Vaccine Core Enzyme Players Market Share by Revenue
2.8.3 Global mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global mRNA Vaccine Core Enzyme Market Scenario by Region
3.1 Global mRNA Vaccine Core Enzyme Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2019-2030
3.2.1 Global mRNA Vaccine Core Enzyme Sales by Region: 2019-2024
3.2.2 Global mRNA Vaccine Core Enzyme Sales by Region: 2025-2030
3.3 Global mRNA Vaccine Core Enzyme Revenue by Region: 2019-2030
3.3.1 Global mRNA Vaccine Core Enzyme Revenue by Region: 2019-2024
3.3.2 Global mRNA Vaccine Core Enzyme Revenue by Region: 2025-2030
3.4 North America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.4.1 North America mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.4.3 North America mRNA Vaccine Core Enzyme Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.5.1 Europe mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.5.3 Europe mRNA Vaccine Core Enzyme Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Vaccine Core Enzyme Market Facts & Figures by Region
3.6.1 Asia Pacific mRNA Vaccine Core Enzyme Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2019-2030)
3.6.3 Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.7.1 Latin America mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.7.3 Latin America mRNA Vaccine Core Enzyme Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Vaccine Core Enzyme Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2019-2030)
3.8.3 Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Enzyme Type
4.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2030)
4.1.1 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2019-2024)
4.1.2 Global mRNA Vaccine Core Enzyme Sales by Enzyme Type (2025-2030)
4.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2030)
4.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2030)
4.2.1 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2019-2024)
4.2.2 Global mRNA Vaccine Core Enzyme Revenue by Enzyme Type (2025-2030)
4.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2030)
4.3 Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2019-2030)
5 Segment by Application
5.1 Global mRNA Vaccine Core Enzyme Sales by Application (2019-2030)
5.1.1 Global mRNA Vaccine Core Enzyme Sales by Application (2019-2024)
5.1.2 Global mRNA Vaccine Core Enzyme Sales by Application (2025-2030)
5.1.3 Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2030)
5.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2019-2030)
5.2.1 Global mRNA Vaccine Core Enzyme Revenue by Application (2019-2024)
5.2.2 Global mRNA Vaccine Core Enzyme Revenue by Application (2025-2030)
5.2.3 Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2030)
5.3 Global mRNA Vaccine Core Enzyme Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 NEB
6.2.1 NEB Company Information
6.2.2 NEB Description and Business Overview
6.2.3 NEB mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.2.4 NEB mRNA Vaccine Core Enzyme Product Portfolio
6.2.5 NEB Recent Developments/Updates
6.3 TriLink Bio Technologies
6.3.1 TriLink Bio Technologies Company Information
6.3.2 TriLink Bio Technologies Description and Business Overview
6.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Portfolio
6.3.5 TriLink Bio Technologies Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck mRNA Vaccine Core Enzyme Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Aldevron
6.5.1 Aldevron Company Information
6.5.2 Aldevron Description and Business Overview
6.5.3 Aldevron mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aldevron mRNA Vaccine Core Enzyme Product Portfolio
6.5.5 Aldevron Recent Developments/Updates
6.6 Qiagen N.V.
6.6.1 Qiagen N.V. Company Information
6.6.2 Qiagen N.V. Description and Business Overview
6.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Product Portfolio
6.6.5 Qiagen N.V. Recent Developments/Updates
6.7 Promega
6.7.1 Promega Company Information
6.7.2 Promega Description and Business Overview
6.7.3 Promega mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Promega mRNA Vaccine Core Enzyme Product Portfolio
6.7.5 Promega Recent Developments/Updates
6.8 Roche CustomBiotech
6.8.1 Roche CustomBiotech Company Information
6.8.2 Roche CustomBiotech Description and Business Overview
6.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Product Portfolio
6.8.5 Roche CustomBiotech Recent Developments/Updates
6.9 Takara Bio Inc.
6.9.1 Takara Bio Inc. Company Information
6.9.2 Takara Bio Inc. Description and Business Overview
6.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Product Portfolio
6.9.5 Takara Bio Inc. Recent Developments/Updates
6.10 Novoprotein
6.10.1 Novoprotein Company Information
6.10.2 Novoprotein Description and Business Overview
6.10.3 Novoprotein mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novoprotein mRNA Vaccine Core Enzyme Product Portfolio
6.10.5 Novoprotein Recent Developments/Updates
6.11 Vazyme
6.11.1 Vazyme Company Information
6.11.2 Vazyme Description and Business Overview
6.11.3 Vazyme mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vazyme mRNA Vaccine Core Enzyme Product Portfolio
6.11.5 Vazyme Recent Developments/Updates
6.12 Hongene Biotech Corporatio
6.12.1 Hongene Biotech Corporatio Company Information
6.12.2 Hongene Biotech Corporatio Description and Business Overview
6.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Portfolio
6.12.5 Hongene Biotech Corporatio Recent Developments/Updates
6.13 Yeasen Biotechnology
6.13.1 Yeasen Biotechnology Company Information
6.13.2 Yeasen Biotechnology Description and Business Overview
6.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Portfolio
6.13.5 Yeasen Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Vaccine Core Enzyme Industry Chain Analysis
7.2 mRNA Vaccine Core Enzyme Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Vaccine Core Enzyme Production Mode & Process
7.4 mRNA Vaccine Core Enzyme Sales and Marketing
7.4.1 mRNA Vaccine Core Enzyme Sales Channels
7.4.2 mRNA Vaccine Core Enzyme Distributors
7.5 mRNA Vaccine Core Enzyme Customers
8 mRNA Vaccine Core Enzyme Market Dynamics
8.1 mRNA Vaccine Core Enzyme Industry Trends
8.2 mRNA Vaccine Core Enzyme Market Drivers
8.3 mRNA Vaccine Core Enzyme Market Challenges
8.4 mRNA Vaccine Core Enzyme Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global mRNA Vaccine Core Enzyme Market Value Comparison by Enzyme Type (2024-2030) & (US$ Million)
Table 2. Global mRNA Vaccine Core Enzyme Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global mRNA Vaccine Core Enzyme Market Competitive Situation by Manufacturers in 2023
Table 4. Global mRNA Vaccine Core Enzyme Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global mRNA Vaccine Core Enzyme Sales Market Share by Manufacturers (2019-2024)
Table 6. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global mRNA Vaccine Core Enzyme Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market mRNA Vaccine Core Enzyme Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of mRNA Vaccine Core Enzyme, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Product Type & Application
Table 12. Global Key Manufacturers of mRNA Vaccine Core Enzyme, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Vaccine Core Enzyme by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Core Enzyme as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Vaccine Core Enzyme Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global mRNA Vaccine Core Enzyme Sales by Region (2019-2024) & (K Units)
Table 18. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2019-2024)
Table 19. Global mRNA Vaccine Core Enzyme Sales by Region (2025-2030) & (K Units)
Table 20. Global mRNA Vaccine Core Enzyme Sales Market Share by Region (2025-2030)
Table 21. Global mRNA Vaccine Core Enzyme Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2019-2024)
Table 23. Global mRNA Vaccine Core Enzyme Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global mRNA Vaccine Core Enzyme Revenue Market Share by Region (2025-2030)
Table 25. North America mRNA Vaccine Core Enzyme Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America mRNA Vaccine Core Enzyme Sales by Country (2019-2024) & (K Units)
Table 27. North America mRNA Vaccine Core Enzyme Sales by Country (2025-2030) & (K Units)
Table 28. North America mRNA Vaccine Core Enzyme Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America mRNA Vaccine Core Enzyme Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe mRNA Vaccine Core Enzyme Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe mRNA Vaccine Core Enzyme Sales by Country (2019-2024) & (K Units)
Table 32. Europe mRNA Vaccine Core Enzyme Sales by Country (2025-2030) & (K Units)
Table 33. Europe mRNA Vaccine Core Enzyme Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe mRNA Vaccine Core Enzyme Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific mRNA Vaccine Core Enzyme Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific mRNA Vaccine Core Enzyme Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America mRNA Vaccine Core Enzyme Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America mRNA Vaccine Core Enzyme Sales by Country (2019-2024) & (K Units)
Table 42. Latin America mRNA Vaccine Core Enzyme Sales by Country (2025-2030) & (K Units)
Table 43. Latin America mRNA Vaccine Core Enzyme Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America mRNA Vaccine Core Enzyme Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa mRNA Vaccine Core Enzyme Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa mRNA Vaccine Core Enzyme Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global mRNA Vaccine Core Enzyme Sales (K Units) by Enzyme Type (2019-2024)
Table 51. Global mRNA Vaccine Core Enzyme Sales (K Units) by Enzyme Type (2025-2030)
Table 52. Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2019-2024)
Table 53. Global mRNA Vaccine Core Enzyme Sales Market Share by Enzyme Type (2025-2030)
Table 54. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Enzyme Type (2019-2024)
Table 55. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Enzyme Type (2025-2030)
Table 56. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2019-2024)
Table 57. Global mRNA Vaccine Core Enzyme Revenue Market Share by Enzyme Type (2025-2030)
Table 58. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2019-2024)
Table 59. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2025-2030)
Table 60. Global mRNA Vaccine Core Enzyme Sales (K Units) by Application (2019-2024)
Table 61. Global mRNA Vaccine Core Enzyme Sales (K Units) by Application (2025-2030)
Table 62. Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2019-2024)
Table 63. Global mRNA Vaccine Core Enzyme Sales Market Share by Application (2025-2030)
Table 64. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Application (2019-2024)
Table 65. Global mRNA Vaccine Core Enzyme Revenue (US$ Million) by Application (2025-2030)
Table 66. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2019-2024)
Table 67. Global mRNA Vaccine Core Enzyme Revenue Market Share by Application (2025-2030)
Table 68. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2019-2024)
Table 69. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2025-2030)
Table 70. Thermo Fisher Company Information
Table 71. Thermo Fisher Description and Business Overview
Table 72. Thermo Fisher mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Thermo Fisher mRNA Vaccine Core Enzyme Product
Table 74. Thermo Fisher Recent Developments/Updates
Table 75. NEB Company Information
Table 76. NEB Description and Business Overview
Table 77. NEB mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. NEB mRNA Vaccine Core Enzyme Product
Table 79. NEB Recent Developments/Updates
Table 80. TriLink Bio Technologies Company Information
Table 81. TriLink Bio Technologies Description and Business Overview
Table 82. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product
Table 84. TriLink Bio Technologies Recent Developments/Updates
Table 85. Merck Company Information
Table 86. Merck Description and Business Overview
Table 87. Merck mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Merck mRNA Vaccine Core Enzyme Product
Table 89. Merck Recent Developments/Updates
Table 90. Aldevron Company Information
Table 91. Aldevron Description and Business Overview
Table 92. Aldevron mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Aldevron mRNA Vaccine Core Enzyme Product
Table 94. Aldevron Recent Developments/Updates
Table 95. Qiagen N.V. Company Information
Table 96. Qiagen N.V. Description and Business Overview
Table 97. Qiagen N.V. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Qiagen N.V. mRNA Vaccine Core Enzyme Product
Table 99. Qiagen N.V. Recent Developments/Updates
Table 100. Promega Company Information
Table 101. Promega Description and Business Overview
Table 102. Promega mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Promega mRNA Vaccine Core Enzyme Product
Table 104. Promega Recent Developments/Updates
Table 105. Roche CustomBiotech Company Information
Table 106. Roche CustomBiotech Description and Business Overview
Table 107. Roche CustomBiotech mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Roche CustomBiotech mRNA Vaccine Core Enzyme Product
Table 109. Roche CustomBiotech Recent Developments/Updates
Table 110. Takara Bio Inc. Company Information
Table 111. Takara Bio Inc. Description and Business Overview
Table 112. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Takara Bio Inc. mRNA Vaccine Core Enzyme Product
Table 114. Takara Bio Inc. Recent Developments/Updates
Table 115. Novoprotein Company Information
Table 116. Novoprotein Description and Business Overview
Table 117. Novoprotein mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Novoprotein mRNA Vaccine Core Enzyme Product
Table 119. Novoprotein Recent Developments/Updates
Table 120. Vazyme Company Information
Table 121. Vazyme Description and Business Overview
Table 122. Vazyme mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Vazyme mRNA Vaccine Core Enzyme Product
Table 124. Vazyme Recent Developments/Updates
Table 125. Hongene Biotech Corporatio Company Information
Table 126. Hongene Biotech Corporatio Description and Business Overview
Table 127. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product
Table 129. Hongene Biotech Corporatio Recent Developments/Updates
Table 130. Yeasen Biotechnology Company Information
Table 131. Yeasen Biotechnology Description and Business Overview
Table 132. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product
Table 134. Yeasen Biotechnology Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. mRNA Vaccine Core Enzyme Distributors List
Table 138. mRNA Vaccine Core Enzyme Customers List
Table 139. mRNA Vaccine Core Enzyme Market Trends
Table 140. mRNA Vaccine Core Enzyme Market Drivers
Table 141. mRNA Vaccine Core Enzyme Market Challenges
Table 142. mRNA Vaccine Core Enzyme Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of mRNA Vaccine Core Enzyme
Figure 2. Global mRNA Vaccine Core Enzyme Market Value Comparison by Enzyme Type (2024-2030) & (US$ Million)
Figure 3. Global mRNA Vaccine Core Enzyme Market Share by Enzyme Type: 2023 & 2030
Figure 4. Capping Enzyme Product Picture
Figure 5. 2'-O-Methyltransferase Product Picture
Figure 6. Inorganic Pyrophosphatase Product Picture
Figure 7. Poly (A) Polymerase Product Picture
Figure 8. Rnase Inhibitor Product Picture
Figure 9. RNA Polymerase Product Picture
Figure 10. Restriction Enzyme Product Picture
Figure 11. Dnase I Product Picture
Figure 12. Others Product Picture
Figure 13. Global mRNA Vaccine Core Enzyme Market Value by Application (2024-2030) & (US$ Million)
Figure 14. Global mRNA Vaccine Core Enzyme Market Share by Application: 2023 & 2030
Figure 15. Biopharmaceutical Companies
Figure 16. Academic and Research Institutions
Figure 17. Global mRNA Vaccine Core Enzyme Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global mRNA Vaccine Core Enzyme Market Size (2019-2030) & (US$ Million)
Figure 19. Global mRNA Vaccine Core Enzyme Sales (2019-2030) & (K Units)
Figure 20. Global mRNA Vaccine Core Enzyme Average Price (US$/Unit) & (2019-2030)
Figure 21. mRNA Vaccine Core Enzyme Report Years Considered
Figure 22. mRNA Vaccine Core Enzyme Sales Share by Manufacturers in 2023
Figure 23. Global mRNA Vaccine Core Enzyme Revenue Share by Manufacturers in 2023
Figure 24. Global 5 and 10 Largest mRNA Vaccine Core Enzyme Players: Market Share by Revenue in mRNA Vaccine Core Enzyme in 2023
Figure 25. mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global mRNA Vaccine Core Enzyme Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America mRNA Vaccine Core Enzyme Sales Market Share by Country (2019-2030)
Figure 28. North America mRNA Vaccine Core Enzyme Revenue Market Share by Country (2019-2030)
Figure 29. United States mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe mRNA Vaccine Core Enzyme Sales Market Share by Country (2019-2030)
Figure 32. Europe mRNA Vaccine Core Enzyme Revenue Market Share by Country (2019-2030)
Figure 33. Germany mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific mRNA Vaccine Core Enzyme Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific mRNA Vaccine Core Enzyme Revenue Market Share by Region (2019-2030)
Figure 40. China mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. China Taiwan mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Southeast Asia mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America mRNA Vaccine Core Enzyme Sales Market Share by Country (2019-2030)
Figure 48. Mexico mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Colombia mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East and Africa mRNA Vaccine Core Enzyme Sales Market Share by Country (2019-2030)
Figure 53. Middle East and Africa mRNA Vaccine Core Enzyme Revenue Market Share by Country (2019-2030)
Figure 54. Turkey mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE mRNA Vaccine Core Enzyme Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of mRNA Vaccine Core Enzyme by Enzyme Type (2019-2030)
Figure 58. Global Revenue Market Share of mRNA Vaccine Core Enzyme by Enzyme Type (2019-2030)
Figure 59. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Enzyme Type (2019-2030)
Figure 60. Global Sales Market Share of mRNA Vaccine Core Enzyme by Application (2019-2030)
Figure 61. Global Revenue Market Share of mRNA Vaccine Core Enzyme by Application (2019-2030)
Figure 62. Global mRNA Vaccine Core Enzyme Price (US$/Unit) by Application (2019-2030)
Figure 63. mRNA Vaccine Core Enzyme Value Chain
Figure 64. mRNA Vaccine Core Enzyme Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
